Access Programs

Through Project ACTT, Imagia Canexia Health is speeding up cancer testing for targeted treatment selection during and beyond COVID-19 through a minimally invasive circulating tumor DNA (ctDNA) assay. The assay, which requires a blood sample, is available as an alternative to some surgical tissue biopsies for patients with advanced lung or breast cancer in Canada.

Learn More About Project ACTT

Where Oncology Meets AI

We pair the latest advances in oncology with machine learning to provide cancer researchers and professionals with the insights needed to make informed decisions.

Learn More

Our Partners

“We have found the FIND-IT assay to be a reliable, quick and cost-effective tool for identifying driver mutations in fixed tissue samples from across Australia. This has had direct implications for identifying patients suitable for targeted therapies, especially those with lung cancer, colorectal cancer and melanoma. However, the scope of the test is such that there is also interest in the panel for patients with a variety of other cancers, including breast and endometrial cancers.” Professor Graeme Suthers, Sonic Genetics

Our Solutions

Plasma Follow It®

Imagia Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.

Learn About Follow It


Imagia Canexia Health’s Find It & Fusions panels detect mutations and gene fusion events in solid tumor tissue. Tissue profiling can be used to help inform treatment decisions or predict progression of cancer based on somatic mutations found in the tumor.

Learn About Tissue Assays

Imagia Canexia Health Insights Platform

Make more informed treatment decisions by using detailed results for therapeutic recommendations and expertly curated clinical trials information provided in our comprehensive reporting software.

Learn About Our Reports

Your Labs, Our Technology

Perform sophisticated NGS oncology profiling right from your laboratory without the large upfront investment. Pairing our cloud-based analytics, interpretation, and reporting platform allows partner labs access to our proprietary informatics software suite. This suite covers the full stack of molecular and computational quality assurance, genome analytics, mutation interpretation, and report generation.

Discover Our Technology

Recent Resources


May 15, 2023

Poster sessions at AACR: a recap

We were grateful for the opportunity to attend and present at the AACR Annual Meeting last week, where three of our scientists highlighted some of the exciting work happening in our Vancouver lab.

Stay Connected

Don’t miss out on news, webinars, and other resources from Imagia Canexia Health. Subscribe to our mailing list to stay up to date on the latest. You can opt-out at any time.

Get in Touch

Contact us today to learn about our end-to-end solution, from mutation identification to auto-generated clinical reports.

Contact Us Today